High Tide Inc. 2LYA.F FSX · Healthcare · Canada
2.22 € -0.89% -0.02 €
Summary
36 / 100 · Bulios Score
What speaks for it
- Revenue grew by 19% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 28% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 11.6 years of operating profit.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue grew by 48% a year over 5 years. Over the last 3 years it grew by 19% a year. For the next fiscal year analysts expect revenue to grow by 28%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $33.3M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 1
- Sell 0
No analyst has published a price target.
75% of the analysts recommend buying.
Analysts in detail